Fortune: A $200 debit card won’t put a dent in seniors’ drug costs
Information about this website: Following the March 2026 merger of Patient Advocate Foundation and the PAN Foundation, this website is now a part of Patient Advocate Foundation and remains active during our website transition.
Where to find information during our transition:
- About the merged organization: uniting.patientadvocate.org
- Financial assistance: totalassist.org
- Additional direct patient services and resources: patientadvocate.org
- Education: panfoundation.org and education.patientadvocate.org
- Clinical trials education: clinicaltrials.panfoundation.org
- Advocacy: npaf.org
- Research: patientinsightinstitute.org
Policy experts say that what Medicare beneficiaries really need are sweeping federal changes to close the gap between what their health insurance pays and what drugs cost them. PAN Foundation President and CEO Dan Klein comments on how the Trump administration’s proposal to provide $200 debit cards to seniors would be better served focusing on people with serious illnesses who have high out-of-pocket drug costs.